Understanding In Vitro Pathways to Drug Discovery for TDP-43 Proteinopathies

The use of cellular models is a common means to investigate the potency of therapeutics in pre-clinical drug discovery. However, there is currently no consensus on which model most accurately replicates key aspects of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) pathology, s...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Hei W. A., Callis, Timothy B., Montgomery, Andrew P., Danon, Jonathan J., Jorgensen, William T., Ke, Yazi D., Ittner, Lars M., Werry, Eryn L., Kassiou, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738080/
https://www.ncbi.nlm.nih.gov/pubmed/36499097
http://dx.doi.org/10.3390/ijms232314769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738080/
https://www.ncbi.nlm.nih.gov/pubmed/36499097
http://dx.doi.org/10.3390/ijms232314769

Ejemplares similares